Green Synthesis and Characterization of Silver Nanoparticles from Eclipta alba and Its Activity Against Triple-Negative Breast Cancer Cell Line (MDA-MB-231)

Author:

Mani Suresh Thanjavur,Jayakumar P.,Pavithra Marimuthu E.,Saranya K.,Rathinavel ThirumalaisamyORCID,Ammashi Subramanian

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Reference36 articles.

1. Zhang, Z., Zhou, Li., Xie, Na., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020). Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduction and Target Therapy. https://doi.org/10.1038/s41392-020-00213-8

2. Sindhu, M. S., Poonkothai, M., & Thirumalaisamy, R. (2022). Phenolic and terpene compounds from Plectranthus amboinicus (Lour.) Spreng act as promising hepatic anticancer agents screened through in silico and in vitro approaches, South African. Journal of Botany, 149, 145–159. https://doi.org/10.1016/j.sajb.2022.06.001

3. Thirumalaisamy, R., Bhuvaneswari, M., Haritha, S., Jeevarathna, S., Sai Janani, K. S., & Suresh, K. (2022). Curcumin, naringenin and Resveratrol from natural plant products hold promising solution for modern world diseases–A recent review. South African Journal of Botany, 151, 567–580.

4. Srinivasan, R., Kamalanathan, D., Rathinavel, T., Iqbal, M. N., & Shanmugam, G. (2023). Anti-cancer potentials of aervine validated through in silico molecular docking, dynamics simulations, pharmacokinetic prediction and in vitro assessment of caspase—3 in SW480 cell line. Molecular Simulation. https://doi.org/10.1080/08927022.2023.2193646

5. Orrantia-Borunda, E., Anchondo-Nuñez, P., Acuña-Aguilar, LE., Octavia Gomez - Valles, F., Ramirez – Valdespino. C.A., & Mayrovitz, H. N. (2022). Sub Types of Breast Cancer In Breast Cancer [Internet]. Brisbane (AU); Exon Publications; Aug 6. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK583808/ doi: https://doi.org/10.36255/exon-publications-breast-cancer-subtypes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3